Follow-On Funding for Regenerative Medicine Innovations
Funds the next development stage, TRL 5 and up, for regenerative-medicine results that already came out of an earlier, completed EU-funded research project.
European CommissionGrant
About
The European Commission funds Innovation Actions that must build directly on a named, completed, multi-beneficiary EU grant, justify how the new consortium differs from the earlier one, and set concrete commercial or deployment milestones. Four awards are expected from this pilot mechanism.
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.